Jiangxi Boya Bio-Pharmaceutical Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangxi Boya Bio-Pharmaceutical Co Ltd with three other
pharmaceutical manufacturers in Asia:
Panacea Biotec Ltd
sales of 6.53 billion Indian Rupees [US$99.92 million]
of which 59%
Essex Bio-Technology Limited
of Hong Kong
(775.66 million Hong Kong Dollars [US$99.88 million]
based in South Korea
(133.26 billion Korean Won [US$118.60 million]
of which 100%
During the year ended December of 2016, sales at
Jiangxi Boya Bio-Pharmaceutical Co Ltd were 946.57 million Chinese Renmimbi (US$137.44 million).
increase of 74.3%
versus 2015, when the company's sales were 543.10 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jiangxi Boya Bio-Pharmaceutical Co Ltd
(and since 2011, sales have increased a total of 381%).
Sales of Bio-Pharmaceuticals saw an increase
that was more than double the company's growth rate: sales were up
1,065.6% in 2016, from
18.56 million Chinese Renmimbi to 216.29 million Chinese Renmimbi.